Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study
| Image |  |
|---|---|
| Description | scientific article published on 17 April 2019 |
| Author/s | |
| Publication date | April 17, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |